A new method employing a known compound, bupropion hydrochloride (..+-..)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride, and its analogues, in a new use for the treatment of TNF-related disorders is described.

 
Web www.patentalert.com

< Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems

< Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis

> System for early detection of disease and development of disease-specific biomarkers

> Systems and methods for temperature adjustment using bodily fluids as a thermic medium
~ 00280